REGENXBIO Inc.RGNXNASDAQ
Loading
Year-over-year book value per share growth
Latest
-36.45%
↓ 2130% vs avg
Percentile
P0
Near historical low
Streak
3 qtr
Consecutive declineDecelerating
Average
-1.63%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -36.45% |
| Q3 2025 | -24.74% |
| Q2 2025 | -22.25% |
| Q1 2025 | 4.59% |
| Q4 2024 | -13.98% |
| Q3 2024 | -13.79% |
| Q2 2024 | -19.43% |
| Q1 2024 | 20.57% |
| Q4 2023 | -14.25% |
| Q3 2023 | -11.38% |
| Q2 2023 | -12.91% |
| Q1 2023 | -10.21% |
| Q4 2022 | -8.54% |
| Q3 2022 | -10.87% |
| Q2 2022 | -8.93% |
| Q1 2022 | -10.12% |
| Q4 2021 | 65.08% |
| Q3 2021 | -9.29% |
| Q2 2021 | -10.01% |
| Q1 2021 | 31.34% |
| Q4 2020 | -9.30% |
| Q3 2020 | 4.24% |
| Q2 2020 | -5.69% |
| Q1 2020 | -7.48% |
| Q4 2019 | -3.87% |
| Q3 2019 | -5.61% |
| Q2 2019 | 0.71% |
| Q1 2019 | -5.38% |
| Q4 2018 | -2.63% |
| Q3 2018 | 47.01% |
| Q2 2018 | 4.49% |
| Q1 2018 | 60.29% |
| Q4 2017 | -6.27% |
| Q3 2017 | -8.77% |
| Q2 2017 | -13.50% |
| Q1 2017 | 30.66% |
| Q4 2016 | -10.28% |
| Q3 2016 | -8.50% |
| Q2 2016 | -6.08% |
| Q1 2016 | -3.84% |